{Reference Type}: Journal Article
{Title}: Relationship between kisspeptin levels in the third trimester and late-onset fetal growth restriction: A case-control study.
{Author}: Ibanoglu MC;Oskovi-Kaplan ZA;Kara O;Ozgu-Erdinc AS;Şahin D;
{Journal}: Placenta
{Volume}: 140
{Issue}: 0
{Year}: 2023 09 7
{Factor}: 3.287
{DOI}: 10.1016/j.placenta.2023.07.012
{Abstract}: We aimed to investigate whether maternal serum kisspeptin levels are associated with late-onset FGR and contribute to adverse perinatal outcomes.<BR>In this case-control study, a total of 90 pregnant women admitted to the perinatology clinic were enrolled. Forty-five of them were diagnosed with FGR and 45 women with healthy pregnancies formed the control group. Maternal serum levels of kisspeptin 1 were compared.<BR>Median kisspeptin1 serum levels were higher in the group of patients with FGR according to gestational age than in the control group [79.4(3.9-230.2) pg/mL vs. 39.8(0.4-188.3) pg/mL; p = 0.001]. The optimal cut-off value for kisspeptin1 was 30.32 pg/mL, with a positive predictive value of 64.6% (95% CI; 0.54-0.86), negative predictive value of 87.5% (95% CI; 0.44-0.72), positive likelihood ratio 1.75 (95% CI; 1.31-2.32), negative likelihood ratio 0.14 (95% CI; 0.04-0.44).<BR>Kisspeptin1 differed significantly in late-onset FGR compared with the control group. This difference from the control group can be used to estimate late-onset FGR.